Imperva, Inc. (IMPV) Given Average Recommendation of “Hold” by Analysts
Shares of Imperva, Inc. (NASDAQ:IMPV) have earned a consensus recommendation of “Hold” from the twenty-one research firms that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a sell recommendation, seven have given a hold recommendation, nine have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $51.86.
Several analysts recently issued reports on the company. Piper Jaffray Companies reissued a “neutral” rating and issued a $58.00 target price on shares of Imperva in a research note on Friday, October 13th. J P Morgan Chase & Co cut Imperva from a “neutral” rating to an “underweight” rating and set a $45.00 target price on the stock. in a research note on Tuesday. BidaskClub raised Imperva from a “sell” rating to a “hold” rating in a research note on Tuesday, September 12th. KeyCorp reissued a “hold” rating on shares of Imperva in a research note on Tuesday, October 24th. Finally, Evercore ISI reissued a “buy” rating and issued a $56.00 target price on shares of Imperva in a research note on Wednesday, November 8th.
Imperva (NASDAQ IMPV) traded down $0.35 during midday trading on Thursday, hitting $40.45. The company had a trading volume of 372,293 shares, compared to its average volume of 430,390. Imperva has a 12 month low of $37.05 and a 12 month high of $52.40.
A number of institutional investors have recently bought and sold shares of IMPV. SG Americas Securities LLC bought a new stake in Imperva during the 3rd quarter valued at approximately $134,000. First Quadrant L P CA bought a new stake in Imperva during the 3rd quarter valued at approximately $136,000. Ameritas Investment Partners Inc. boosted its position in Imperva by 18.7% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock valued at $141,000 after acquiring an additional 464 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. boosted its position in Imperva by 26.2% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,177 shares of the software maker’s stock valued at $201,000 after acquiring an additional 866 shares in the last quarter. Finally, Amalgamated Bank bought a new stake in Imperva during the 2nd quarter valued at approximately $206,000. 96.95% of the stock is currently owned by institutional investors and hedge funds.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.